• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肯尼亚分离疟原虫株中奎宁和其他抗疟药物的体外活性与 pfnep 多态性。

In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.

机构信息

Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, P.O. Box 230, 80108 Kilifi, Kenya.

出版信息

Antimicrob Agents Chemother. 2010 Aug;54(8):3302-7. doi: 10.1128/AAC.00325-10. Epub 2010 Jun 1.

DOI:10.1128/AAC.00325-10
PMID:20516285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2916339/
Abstract

Resistance to the amino alcohol quinine has been associated with polymorphisms in pfnhe, a sodium hydrogen exchanger. We investigated the role of this gene in quinine resistance in vitro in isolates from Kenya. We analyzed pfnhe whole-gene polymorphisms, using capillary sequencing, and pfcrt at codon 76 (pfcrt-76) and pfmdr1 at codon 86 (pfmdr1-86), using PCR-enzyme restriction methodology, in 29 isolates from Kilifi, Kenya, for association with the in vitro activities of quinine and 2 amino alcohols, mefloquine and halofantrine. In vitro activity was assessed as the drug concentration that inhibits 50% of parasite growth (IC50). The median IC50s of quinine, halofantrine, and mefloquine were 92, 22, and 18 nM, respectively. The presence of 2 DNNND repeats in microsatellite ms4760 of pfnhe was associated with reduced susceptibility to quinine (60 versus 227 nM for 1 and 2 repeats, respectively; P<0.05), while 3 repeats were associated with restoration of susceptibility. The decrease in susceptibility conferred by the 2 DNNND repeats was more pronounced in parasites harboring the pfmdr1-86 mutation. No association was found between susceptibility to quinine and the pfcrt-76 mutation or between susceptibility to mefloquine or halofantrine and the pfnhe gene and the pfcrt-76 and pfmdr1-86 mutations. Using previously published data on the in vitro activities of chloroquine, lumefantrine, piperaquine, and dihydroartemisinin, we investigated the association of their activities with pfnhe polymorphism. With the exception of a modulation of the activity of lumefantrine by a mutation at position 1437, pfnhe did not modulate their activities. Two DNNND repeats combined with the pfmdr1-86 mutation could be used as an indicator of reduced susceptibility to quinine.

摘要

对氨基酸醇奎宁的耐药性与钠氢交换蛋白 pfnhe 的多态性有关。我们研究了该基因在肯尼亚分离株体外奎宁耐药性中的作用。我们使用毛细管测序分析了 pfnhe 全基因多态性,使用 PCR-酶限制方法分析了 pfcrt 76 位密码子(pfcrt-76)和 pfmdr1 86 位密码子(pfmdr1-86),并将 29 个来自肯尼亚基利菲的分离株与体外奎宁和 2 种氨基酸醇(甲氟喹和卤泛群)的活性相关联。体外活性评估为抑制寄生虫生长 50%的药物浓度(IC50)。奎宁、卤泛群和甲氟喹的中位数 IC50 分别为 92、22 和 18 nM。pfnhe 微卫星 ms4760 中存在 2 个 DNNND 重复与对奎宁的敏感性降低相关(分别为 60 和 227 nM,1 和 2 个重复;P<0.05),而 3 个重复与敏感性恢复相关。在携带 pfmdr1-86 突变的寄生虫中,2 个 DNNND 重复引起的敏感性降低更为显著。未发现奎宁敏感性与 pfcrt-76 突变之间、甲氟喹或卤泛群敏感性与 pfnhe 基因和 pfcrt-76 及 pfmdr1-86 突变之间存在相关性。使用先前发表的关于氯喹、青蒿琥酯、哌喹和双氢青蒿素体外活性的数据,我们研究了其活性与 pfnhe 多态性的关联。除了位置 1437 的突变对青蒿琥酯活性的调节外,pfnhe 没有调节其活性。2 个 DNNND 重复与 pfmdr1-86 突变的结合可作为奎宁敏感性降低的指标。

相似文献

1
In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya.肯尼亚分离疟原虫株中奎宁和其他抗疟药物的体外活性与 pfnep 多态性。
Antimicrob Agents Chemother. 2010 Aug;54(8):3302-7. doi: 10.1128/AAC.00325-10. Epub 2010 Jun 1.
2
Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum.恶性疟原虫 Na+/H+ 交换蛋白多态性与奎宁反应的差异关联:来自现场和培养适应的恶性疟原虫分离株的研究。
Antimicrob Agents Chemother. 2011 Dec;55(12):5834-41. doi: 10.1128/AAC.00477-11. Epub 2011 Sep 26.
3
Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from western Kenya.Pfmdr1、Pfcrt和Pfnhe1基因的多态性与肯尼亚西部恶性疟原虫分离株中奎宁体外活性降低有关。
Antimicrob Agents Chemother. 2014 Jul;58(7):3737-43. doi: 10.1128/AAC.02472-14. Epub 2014 Apr 21.
4
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo.体外奎宁敏感性与恶性疟原虫 Na+/H+ 交换蛋白(Pfnhe-1)基因微卫星变异:来自刚果共和国临床分离株的无关联性。
Malar J. 2011 Feb 11;10:37. doi: 10.1186/1475-2875-10-37.
5
Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum.pfmdr1 基因而非 pfnhe-1 基因的多态性与泰国恶性疟原虫分离株体外奎宁敏感性相关。
Malar J. 2012 Jan 5;11:7. doi: 10.1186/1475-2875-11-7.
6
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.恶性疟原虫的钠/氢交换体1转运蛋白与对奎宁的敏感性降低有关。
Antimicrob Agents Chemother. 2009 May;53(5):1926-30. doi: 10.1128/AAC.01243-08. Epub 2009 Mar 9.
7
In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger transporter (Pfnhe-1) gene in 393 isolates from Dakar, Senegal.来自塞内加尔达喀尔的 393 个分离株中,恶性疟原虫 Na+/H+ 交换转运蛋白(Pfnhe-1)基因的奎宁体外敏感性与微卫星变异。
Malar J. 2013 Jun 7;12:189. doi: 10.1186/1475-2875-12-189.
8
Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.恶性疟原虫 Na+/H+ 交换蛋白(Pfnhe-1)基因微卫星变异与体外奎宁敏感性降低的关联:来自非洲临床分离株的缺乏证实。
Am J Trop Med Hyg. 2010 May;82(5):782-7. doi: 10.4269/ajtmh.2010.09-0327.
9
Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in Uganda.在乌干达,疟原虫 pfcrt、pfmdr1 和 pfnhe1 多态性对预测奎宁体外敏感性或临床疗效的能力有限。
Antimicrob Agents Chemother. 2011 Feb;55(2):615-22. doi: 10.1128/AAC.00954-10. Epub 2010 Nov 15.
10
Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.Pfmdr1在恶性疟原虫对氯喹、奎宁、单去乙基氨喹啉、甲氟喹、本芴醇和双氢青蒿素的体外易感性中的作用。
Antimicrob Agents Chemother. 2014 Dec;58(12):7032-40. doi: 10.1128/AAC.03494-14. Epub 2014 Sep 8.

引用本文的文献

1
The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides.关键糖酵解酶磷酸果糖激酶参与抗疟糖苷耐药性。
mBio. 2020 Dec 8;11(6):e02842-20. doi: 10.1128/mBio.02842-20.
2
Analysis of Plasmodium falciparum Na/H exchanger (pfnhe1) polymorphisms among imported African malaria parasites isolated in Wuhan, Central China.中国中部武汉地区输入性非洲疟原虫 PfNHE1 基因多态性分析。
BMC Infect Dis. 2019 Apr 29;19(1):354. doi: 10.1186/s12879-019-3921-7.
3
Amodiaquine resistance in is associated with His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters.[具体病原体名称]中的阿莫地喹耐药性与His95Pro突变、氯喹、青蒿素和伯氨喹敏感性丧失以及关键转运蛋白的高转录水平有关。
Wellcome Open Res. 2017 Jun 20;2:44. doi: 10.12688/wellcomeopenres.11768.2. eCollection 2017.
4
Screening of a library of traditional Chinese medicines to identify anti-malarial compounds and extracts.筛选中药文库以鉴定抗疟化合物和提取物。
Malar J. 2018 Jun 25;17(1):244. doi: 10.1186/s12936-018-2392-4.
5
Antimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR Network.抗疟药物耐药性:文献综述及ICEMR网络的活动与发现
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):57-68. doi: 10.4269/ajtmh.15-0007. Epub 2015 Aug 10.
6
Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy.在引入青蒿素联合疗法之前,坦桑尼亚穆赫扎地区恶性疟原虫pfcrt、pfmdr1和pfnhe1中与抗疟药耐药性相关的多态性的流行情况。
Malar J. 2015 Mar 25;14:129. doi: 10.1186/s12936-015-0642-2.
7
The MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, Kenya.MSPDBL2基因第591位密码子多态性与肯尼亚基利菲恶性疟原虫分离株中卤泛群的体外药物反应相关。
Antimicrob Agents Chemother. 2015 Mar;59(3):1770-5. doi: 10.1128/AAC.03522-14. Epub 2014 Dec 22.
8
Challenges of drug-resistant malaria.耐药疟疾的挑战。
Parasite. 2014;21:61. doi: 10.1051/parasite/2014059. Epub 2014 Nov 18.
9
Reduced in vitro doxycycline susceptibility in plasmodium falciparum field isolates from Kenya is associated with PfTetQ KYNNNN sequence polymorphism.肯尼亚恶性疟原虫野外分离株对多西环素的体外敏感性降低与PfTetQ KYNNNN序列多态性有关。
Antimicrob Agents Chemother. 2014 Oct;58(10):5894-9. doi: 10.1128/AAC.02788-13. Epub 2014 Jul 28.
10
A HECT ubiquitin-protein ligase as a novel candidate gene for altered quinine and quinidine responses in Plasmodium falciparum.一种HECT泛素蛋白连接酶作为恶性疟原虫中奎宁和奎尼丁反应改变的新候选基因。
PLoS Genet. 2014 May 15;10(5):e1004382. doi: 10.1371/journal.pgen.1004382. eCollection 2014 May.

本文引用的文献

1
In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.在乌干达,体外疟原虫对不同抗疟药物的敏感性。
Antimicrob Agents Chemother. 2010 Mar;54(3):1200-6. doi: 10.1128/AAC.01412-09. Epub 2010 Jan 11.
2
Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.监测来自泰缅边境地区恶性疟原虫分离株对氯喹、奎宁、甲氟喹和青蒿琥酯的体外敏感性和耐药性分子标志物。
Acta Trop. 2010 Feb;113(2):190-4. doi: 10.1016/j.actatropica.2009.10.016. Epub 2009 Oct 30.
3
In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1.在肯尼亚恶性疟原虫分离株中哌喹、青蒿琥酯和二氢青蒿素的体外活性以及 pfcrt 和 pfmdr1 的多态性。
Antimicrob Agents Chemother. 2009 Dec;53(12):5069-73. doi: 10.1128/AAC.00638-09. Epub 2009 Sep 21.
4
Artemisinin resistance in Plasmodium falciparum malaria.恶性疟原虫疟疾中的青蒿素耐药性。
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
5
Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.奎宁与蒿甲醚-本芴醇治疗乌干达儿童单纯性恶性疟的疗效比较:随机试验
BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.
6
In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa.在东非持续使用4-氨基喹啉的地区,阿莫地喹对恶性疟原虫的体内和体外疗效。
J Infect Dis. 2009 Jun 1;199(11):1575-82. doi: 10.1086/598862.
7
Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.恶性疟原虫的钠/氢交换体1转运蛋白与对奎宁的敏感性降低有关。
Antimicrob Agents Chemother. 2009 May;53(5):1926-30. doi: 10.1128/AAC.01243-08. Epub 2009 Mar 9.
8
Artesunate versus quinine for treating severe malaria.青蒿琥酯与奎宁治疗重症疟疾的比较。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD005967. doi: 10.1002/14651858.CD005967.pub2.
9
Extensive genetic diversity in the Plasmodium falciparum Na+/H+ exchanger 1 transporter protein implicated in quinine resistance.恶性疟原虫钠/氢交换体1转运蛋白中与奎宁抗性相关的广泛遗传多样性。
Antimicrob Agents Chemother. 2007 Dec;51(12):4508-11. doi: 10.1128/AAC.00317-07. Epub 2007 Oct 8.
10
Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004 2006.2004年至2006年从科摩罗进口到法国马赛的248株恶性疟原虫分离株中的抗疟药物敏感性及与耐药性相关的点突变
Am J Trop Med Hyg. 2007 Sep;77(3):431-7.